Development, validation and integration of in silico models to identify androgen active chemicals

被引:23
|
作者
Manganelli, Serena [1 ]
Roncaglioni, Alessandra [1 ]
Mansouri, Kamel [2 ,3 ,4 ]
Judson, Richard S. [2 ]
Benfenati, Emilio [1 ]
Manganaro, Alberto [1 ]
Ruiz, Patricia [5 ]
机构
[1] IRCCS, Ist Ric Farmacol Mario Negri, Dept Environm Hlth Sci, Lab Environm Chem & Toxicol, Via G La Masa 19, I-20156 Milan, Italy
[2] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA
[3] Oak Ridge Inst Sci & Educ, 1299 Bethel Valley Rd, Oak Ridge, TN 37830 USA
[4] Integrated Lab Syst Inc, 601 Keystone Dr, Morrisville, NC 27650 USA
[5] Agcy Tox Subst & Dis Registry, Div Toxicol & Human Hlth Sci, Computat Toxicol & Methods Dev Lab, 1600 Clifton Rd,MS-F57, Atlanta, GA 30333 USA
关键词
Endocrine disrupting chemicals; High-throughput screening; Androgen receptor; In silico; Artificial neural networks; Support vector machine; Decision tree; ENDOCRINE-DISRUPTING CHEMICALS; CLASSIFICATION MODELS; TOXCAST PROGRAM; MUTAGENICITY; BINDING;
D O I
10.1016/j.chemosphere.2018.12.131
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Humans are exposed to large numbers of environmental chemicals, some of which potentially interfere with the endocrine system. The identification of potential endocrine disrupting chemicals (EDCs) has gained increasing priority in the assessment of environmental hazards. The U.S. Environmental Protection Agency (U.S. EPA) has developed the Endocrine Disruptor Screening Program (EDSP) which aims to prioritize and screen potential EDCs. The Toxicity Forecaster (ToxCast) program has generated data using in vitro high-throughput screening (HTS) assays measuring activity of chemicals at multiple points along the androgen receptor (AR) activity pathway. In the present study, using a large and diverse data set of 1667 chemicals provided by the U.S. EPA from the combined ToxCast AR assays in the framework of the Collaborative Modeling Project for Androgen Receptor Activity (CoMPARA). Two models were built using ADMET Predictor (TM); one is based on Artificial Neural Networks (ANNs) technology and the other uses a Support Vector Machine (SVM) algorithm; one model is a Decision Tree (DT) developed in R; and two models make use of differently combined sets of structural alerts (SAs) automatically extracted by SARpy. We used two strategies to integrate predictions from single models; one is based on a majority vote approach and the other on prediction convergence. These strategies led to enhanced statistical performance in most cases. Moreover, the majority vote approach improved prediction coverage when one or more single models were not able to provide any estimations. This study integrates multiple in silico approaches as a virtual screening tool for use in risk assessment of endocrine disrupting chemicals. Published by Elsevier Ltd.
引用
收藏
页码:204 / 215
页数:12
相关论文
共 50 条
  • [21] In silico prioritization for endocrine active substances (EAS) and their in vitro validation
    Eberini, I.
    Palazzolo, L.
    Peijnenburg, A.
    Guerrini, U.
    Parravicini, C.
    Moretto, A.
    Bovee, T.
    TOXICOLOGY LETTERS, 2016, 258 : S120 - S120
  • [22] Development of new in silico methods to identify ligands for orphan GPCR
    Nathanael Weill
    Didier Rognan
    Chemistry Central Journal, 2 (Suppl 1)
  • [23] Development and validation of algorithms to identify acute diverticulitis
    Kawatkar, Aniket
    Chu, Li-Hao
    Iyer, Rajan
    Yen, Linnette
    Chen, Wansu
    Erder, M. Haim
    Hodgkins, Paul
    Longstreth, George
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 (01) : 27 - 37
  • [24] Validation of tree models to identify individuals with insulin resistance
    Williams, K
    Tripathy, D
    Groop, L
    Stern, MP
    DIABETES, 2004, 53 : A319 - A319
  • [25] Endocrine Disrupting Chemicals and Hippocampal Development: The Role of Estrogen and Androgen Signalling
    Lupu, Diana-Ioana
    Ulloa, Andrea Cediel
    Ruegg, Joelle
    NEUROENDOCRINOLOGY, 2023, 113 (12) : 1193 - 1214
  • [26] Development of an in silico model to evaluate in vivo chromosome damaging potential of chemicals
    Van Bossuyt, M.
    Raitano, G.
    Van Hoeck, E.
    Rogiers, V.
    Benfenati, E.
    Mertens, B.
    TOXICOLOGY LETTERS, 2018, 295 : S98 - S98
  • [27] Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD models
    Kapitulnik, Jaime
    Pelkonen, Olavi
    Gundert-Remy, Ursula
    Dahl, Svein G.
    Boobis, Alan R.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (07) : 867 - 887
  • [28] Experiences of tool integration: Development and validation
    Pesola, J-P
    Eskeli, J.
    Parviainen, P.
    Kommeren, R.
    Gramza, M.
    ENTERPRISE INTEROPERABILITY III: NEW CHALLENGES AND INDUSTRIAL APPROACHES, 2008, : 499 - +
  • [29] Models of technological integration development
    Miller, Alexander
    Miller, Maxim
    STRATEGIC MANAGEMENT, 2021, 26 (04): : 15 - 27
  • [30] Development and Validation of a Computational Model for Androgen Receptor Activity
    Kleinstreuer, Nicole C.
    Ceger, Patricia
    Watt, Eric D.
    Martin, Matthew
    Houck, Keith
    Browne, Patience
    Thomas, Russell S.
    Casey, Warren M.
    Dix, David J.
    Allen, David
    Sakamuru, Srilatha
    Xia, Menghang
    Huang, Ruili
    Judson, Richard
    CHEMICAL RESEARCH IN TOXICOLOGY, 2017, 30 (04) : 946 - 964